Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
CRO
Merck KGaA rolls out ‘all-in-one’ CHO genetic stability assay
The platform, called Aptegra, reportedly cuts biosafety testing time for clients by two-thirds, speeding up the commercialization process.
Helen Floersh
Apr 18, 2024 4:05pm
Merck KGaA signs $1.4B biobuck ADC deal with Caris
Apr 4, 2024 8:25am
Merck KGaA drops evobrutinib in wake of double phase 3 fail
Mar 7, 2024 9:54am
Merck KGaA paying $16M to join C4's protein degrader hunt
Mar 4, 2024 10:18am
2023's top 10 clinical trial flops
Jan 22, 2024 6:00am
Avenzo, Merck KGaA and AbbVie each ink new cancer deals
Jan 4, 2024 10:26am